Canadian medical cannabis producer Tilray launches IPO

Canadian medical cannabis producer Tilray launches IPO

NASDAQ now offers some unusual shares: Tilray, a global leader in medical cannabis research, cultivation, processing, and distribution, launched the first IPO in this sphere. Tilray is offering 9 million shares of Class 2 at the opening price of $23,05 per share. The company intends to grant underwriters a 30-day over-allotment option to purchase up to 1,350,000 of additional shares.

The ticker of the share is NASDAQ:TLRY and it’s already available in the default list of the stock section in EXANTE Trading Platform.

Tilray is the first GMP-certified medical cannabis producer to supply cannabis products to tens of thousands of patients, physicians, pharmacies, hospitals, and researchers. With its branches located in Europe, USA and Canada, it operates all over the world from Chile to New Zealand.

The information in this text is provided to you for informational purposes only and should not be regarded as an offer or solicitation of an offer to buy or sell any investments or related services that may be referenced here.

Prossimo articolo
Sviluppato da professionisti per professionisti.
privacy protect
Ufficio di rappresentanza più vicino:  28 Oktovriou, 365
Vashiotis Seafront Building
Flats 102, 103, 501,
3107, Limassol, Cipro, +357 2534 2627
Versione 0.4.193-b1fa3c81 remotes/origin/master
EXANTE dona $1 milione a sostegno dei bambini in Ucraina

EXANTE ha donato $1 milione per l'intervento d'emergenza dell'UNICEF a sostegno di bambini e famiglie vulnerabili colpite dalla crisi in corso in Ucraina e di coloro che si sono rifugiati nei Paesi vicini.